Submuscular Versus Subcutaneous Pectoral Implantation of Cardioverter-Defibrillators: Effect on High Voltage Pathway Impedance and Defibrillation Efficacy

Journal of Interventional Cardiac Electrophysiology

Volumn 2, Issue 1, 1997, Pages 47-52

  Iskos, Demosthenes ^a   Lock, Kenneth ^b   Lurie, Keith G ^a   Fahy, Gerard J ^a   Petersen Stejskal, Susan ^b   Benditt, David G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Angeion Corporation   (United States)

Author keywords

Defibrillation threshold; Implantable cardioverter defibrillator; Lead impedance

Indexed keywords

EID: 2342597245     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009764823782     Document Type: Article

References (16)

1. Camunas J, Mehta D, Ip J, Pe E, Gomes JA. Total pectoral implantation: a new technique for implantation of transvenous defibrillator lead systems and implantable cardioverter defibrillators. PACE 1993;16:1380-1385.
2. Stanton MS, Hayes DL, Munger TM, Trusty JM, Espinosa RE, Shen WK, Osborn MJ, Packer DL, Hammill SL. Consistent subcutaneous prepectoral implantation of a new implantable cardioverter defibrillator. Mayo Clin Proc 1994; 69:309-314.
3. Poole JE, Bardy GH, Dolack GL, Kudenchuk PJ, Anderson J, Johnson G. A prospective randomized evaluation of implantable cardioverter-defibrillator size on unipolar defibrillation system efficacy. Circulation 1995;92:2940-2943.
4. Markewitz A, Kaulbach H, Mattke S, Dorwarth V, Weinhold C, Hoffmann E, Steinbeck G, Reichart B. One incision approach for insertion of implantable cardioverter-defibrillators. Ann Thorac Surg 1994;58:1609-1613.
5. Foster AH. Technique for implantation of cardioverter defibrillators in the subpectoral position. Ann Thorac Surg 1995;59:764-767.
6. Gold MR, Peters RW, Johnson JW, Shorofsky SR for the Worldwide Jewel Investigators. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol 1996;28:1278-1282.
7. Gold MR, Foster AH, Shorofsky SR. Enhanced defibrillation efficacy with an active pectoral pulse generator. Am J Cardiol 1996;78:540-543.
8. Schwartzman D, Hull ML, Callans DJ, Gottlieb CD, Marchlinski FE. Serial defibrillation lead impedance in patients with epicardial and nonthoracotomy lead systems. J Cardiovasc Electrophysiol 1996;7:697-703.
9. Kirk MM, Shorofsky SR, Khalighi K, Kavesh NG, Peters RW, Gold MR. Chronic rise in monophasic defibrillation thresholds with a transvenous lead system. Am J Cardiol 1997;79:502-505.
10. Gold MR, Kavesh NG, Peters RW, Shorofsky SR. Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system. J Am Coll Cardiol 1997;30:233-236.
11. Hsia HH, Mitra RL, Flores BT, Marchlinski FE. Early post-operative increase in defibrillation threshold with nonthoracotomy system in humans. PACE 1994;17:1166-1173.
12. Schwartzman D, Callans DJ, Gottlieb CD, Heo J, Marchlinski FE. Early postoperative rise in defibrillation threshold in patients with nonthoracotomy defibrillation lead systems: attenuation with biphasic shock waveforms. J Cardiovasc Electrophysiol 1996;7:483-493.
13. Martin DT, John R, Venditti FJ. Increase in defibrillation threshold in non-thoracotomy implantable defibrillators using a biphasic waveform. Am J Cardiol 1995;76:263-266.
14. Bach SM Jr, Monroe P. High power circuitry. In: Kroll MW, Lehmann MH, eds. Implantable Cardioverter-Defibrillator Therapy: The Engineering-Clinical Interface. 1st ed. Norwell, MA: Kluwer Academic Publishers, 1996;257-273.
15. Kalman JM, Power JM, Chen JM, Farish SJ, Tonkin AM. Importance of electrode design, lead configuration and impedance for successful low energy transcatheter atrial defibrillation in dogs. J Am Coll Cardiol 1993;22:1199-1206.
16. Fain ES, Billingham M, Winkle RA. Internal cardiac defibrillation: histopathology and temporal stability of defibrillation energy requirements. J Am Coll Cardiol 1987; 9:631-638.